4//SEC Filing
Kiernan Jane E 4
Accession 0001562180-24-007712
CIK 0001603756other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 9:00 AM ET
Size
8.6 KB
Accession
0001562180-24-007712
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Kiernan Jane E
Director
Transactions
- Disposition to Issuer
Common Stock
2024-11-15$71.00/sh−19,861$1,410,131→ 0 total
Footnotes (1)
- [F1]Reflects the disposition of the reporting person's shares of the Issuer's common stock, upon the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 8, 2024 (the "Merger Agreement"), among the Issuer, Boston Scientific Corporation ("Parent") and Sadie Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger of Merger Sub with and into the Issuer with the Issuer as the surviving corporation (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective time"), each outstanding share of the Issuer's common stock was canceled and converted automatically into the right to receive $71.00 in cash, without interest (The "Merger Consideration").
Issuer
Axonics, Inc.
CIK 0001603756
Entity typeother
Related Parties
1- filerCIK 0001379171
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 9:00 AM ET
- Size
- 8.6 KB